You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Overview

  • Product nameAnti-AP2 beta antibody [AP2b 1F3/8]See all AP2 beta primary antibodies ...
  • Description
    Mouse monoclonal [AP2b 1F3/8] to AP2 beta
  • Tested applicationsWB, ELISA, IHC-Fr more details
  • Species reactivity
    Reacts with: Rat, Human
  • Immunogen

    Truncated AP-2 beta-protein prepared from bacteria.

Properties

Applications

Our Abpromise guarantee covers the use of ab18113 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Notes
WB WB: Use at an assay dependent dilution. Predicted molecular weight: 50 kDa.
ELISA ELISA: Use at an assay dependent dilution.
IHC-Fr IHC-Fr: 1/300.

Target

  • FunctionSequence-specific DNA-binding protein that interacts with inducible viral and cellular enhancer elements to regulate transcription of selected genes. AP-2 factors bind to the consensus sequence 5'-GCCNNNGGC-3' and activate genes involved in a large spectrum of important biological functions including proper eye, face, body wall, limb and neural tube development. They also suppress a number of genes including MCAM/MUC18, C/EBP alpha and MYC. AP-2-beta appears to be required for normal face and limb development and for proper terminal differentiation and function of renal tubular epithelia.
  • Involvement in diseaseDefects in TFAP2B are the cause of Char syndrome (CHAR) [MIM:169100]. CHAR is an autosomal dominant disorder characterized by patent ductus arteriosus (PDA), facial dysmorphism and hand anomalies.
  • Sequence similaritiesBelongs to the AP-2 family.
  • Post-translational
    modifications
    Sumoylated on Lys-21; which inhibits transcriptional activity.
  • Cellular localizationNucleus.
  • Target information above from: UniProt accession Q92481 The UniProt Consortium
    The Universal Protein Resource (UniProt) in 2010
    Nucleic Acids Res. 38:D142-D148 (2010) .

    Information by UniProt
  • Database links
  • Alternative names
      Activating enhancer binding protein 2 beta antibodyActivating enhancer-binding protein 2-beta antibodyAP 2B antibody
      AP2 B antibodyAP2-beta antibodyAP2B antibodyAP2B_HUMAN antibodyAP2beta antibodyMGC21381 antibodyOTTHUMP00000039925 antibodyTFAP 2B antibodyTFAP2B antibodyTranscription factor AP 2 beta antibodyTranscription factor AP-2-beta antibodyTranscription factor AP2 beta antibody
    see all

Anti-AP2 beta antibody [AP2b 1F3/8] images

  • ab18113 at 1/300 staining perfusion fixed rat brain tissue sections by IHC-Fr. Adult rat was perfused intracardially with paraformaldehyde 4% + 15% of a saturated solution of picric acid in PB 0.2M. The brain was post-fixed in the same fixative for 24 hours. Sections were cryoprotected with sucrose 20% and later frozen in OCT. Sections were incubated in free floating 12h with the primary antibody (1/300) and revealed with secondary antibody conjugated with Alexa Fluor ® 488 (1/2000). The staining obtained is restricted to the cytoplasm and consists of a small and thin punctate staining (white arrows). The pictures show the staining obtained in cortical neurons, with the X20 (top picture) and X40 (bottom picture) objective.

    See Abreview

References for Anti-AP2 beta antibody [AP2b 1F3/8] (ab18113)

This product has been referenced in:
  • Ebauer M  et al. Comparative expression profiling identifies an in vivo target gene signature with TFAP2B as a mediator of the survival function of PAX3/FKHR. Oncogene 26:7267-81 (2007). WB ; Human . Read more (PubMed: 17525748) »

See 1 Publication for this product

Product Wall

Filter by Application

Filter by Species

Filter by Ratings

Application Immunohistochemistry (Frozen sections)
Sample Rat Tissue sections (Rat brain)
Specification Rat brain
Fixative Paraformaldehyde
Permeabilization No
Username

Verified customer

Submitted Jun 30 2009

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"